US Stock MarketDetailed Quotes

CytoMed Therapeutics (GDTC)

Watchlist
  • 1.030
  • -0.030-2.83%
Close Mar 26 16:00 ET
  • 1.030
  • 0.0000.00%
Post 20:01 ET
12.09MMarket Cap-4.14P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CytoMed Therapeutics (GDTC) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Total revenue
69.5K
0
0
0
0
Operating revenue
--69.5K
--0
--0
--0
--0
Cost of revenue
17.12K
0
0
Gross profit
52.38K
0
0
Operating expense
-17.17%3.18M
106.99%3.84M
7.43%1.86M
37.57%1.73M
1.26M
Selling and administrative expenses
-1.44%1.27M
223.37%1.28M
36.32%397.11K
47.87%291.32K
--197.01K
-Selling and marketing expense
-28.60%23.78K
--33.31K
--0
-59.87%2.48K
--6.18K
-General and administrative expense
-0.71%1.24M
214.98%1.25M
37.49%397.11K
51.36%288.84K
--190.83K
Research and development costs
20.12%1.91M
4.40%1.59M
39.62%1.52M
5.06%1.09M
--1.04M
Depreciation amortization depletion
17.63%122.4K
-6.88%104.05K
10.38%111.75K
16.86%101.23K
--86.63K
-Depreciation and amortization
17.63%122.4K
-6.88%104.05K
10.38%111.75K
16.86%101.23K
--86.63K
Other taxes
26.29%8.41K
-5.45%6.66K
72.63%7.05K
17.17%4.08K
--3.48K
Other operating expenses
-114.34%-123.11K
571.33%858.3K
-175.58%-182.1K
449.36%240.93K
---68.96K
Operating profit
18.54%-3.13M
-106.99%-3.84M
-7.43%-1.86M
-37.57%-1.73M
-1.26M
Net non-operating interest income expense
26.84%297.36K
290.48%234.44K
-7.65%-123.08K
-8.35%-114.33K
-105.52K
Non-operating interest income
11.18%317.67K
13,525.13%285.72K
-37.76%2.1K
--3.37K
--0
Non-operating interest expense
-60.39%20.31K
-59.03%51.28K
6.35%125.18K
11.54%117.7K
--105.52K
Other net income (expense)
159.40%311.31K
54.43%-524.11K
-449.29%-1.15M
63.51%-209.39K
-573.86K
Gain on sale of security
175.49%297.55K
-1,391.77%-394.16K
-178.68%-26.42K
-2,089.61%-9.48K
---433
Earnings from equity interest
144.12%13.77K
7.00%-31.2K
84.22%-33.55K
---212.58K
--0
Special income (charges)
--0
--0
--280
--0
--0
-Gain on sale of property,plant,equipment
--0
--0
--280
--0
--0
Other non- operating income (expenses)
----
90.94%-98.75K
-8,709.51%-1.09M
102.21%12.67K
---573.42K
Income before tax
38.98%-2.52M
-32.04%-4.13M
-52.53%-3.13M
-6.01%-2.05M
-1.94M
Income tax
0
-60.18%653
1.64K
0
0
Net income
38.98%-2.52M
-31.99%-4.13M
-52.61%-3.13M
-6.01%-2.05M
-1.94M
Net income continuous Operations
38.98%-2.52M
-31.99%-4.13M
-52.61%-3.13M
-6.01%-2.05M
---1.94M
Minority interest income
-1,784.31%-5.16K
-12.76%-274
3.95%-243
-36.02%-253
-186
Net income attributable to the parent company
39.11%-2.52M
-31.99%-4.13M
-52.62%-3.13M
-6.00%-2.05M
-1.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
39.11%-2.52M
-31.99%-4.13M
-52.62%-3.13M
-6.00%-2.05M
-1.94M
Basic earnings per share
43.59%-0.22
-36.26%-0.39
-52.62%-0.2862
-6.00%-0.1875
-0.1769
Diluted earnings per share
43.59%-0.22
-36.26%-0.39
-52.62%-0.2862
-6.00%-0.1875
-0.1769
Dividend per share
Currency Unit
SGD
SGD
SGD
SGD
SGD
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
--
--
(FY)Dec 31, 2024(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Total revenue 69.5K0000
Operating revenue --69.5K--0--0--0--0
Cost of revenue 17.12K00
Gross profit 52.38K00
Operating expense -17.17%3.18M106.99%3.84M7.43%1.86M37.57%1.73M1.26M
Selling and administrative expenses -1.44%1.27M223.37%1.28M36.32%397.11K47.87%291.32K--197.01K
-Selling and marketing expense -28.60%23.78K--33.31K--0-59.87%2.48K--6.18K
-General and administrative expense -0.71%1.24M214.98%1.25M37.49%397.11K51.36%288.84K--190.83K
Research and development costs 20.12%1.91M4.40%1.59M39.62%1.52M5.06%1.09M--1.04M
Depreciation amortization depletion 17.63%122.4K-6.88%104.05K10.38%111.75K16.86%101.23K--86.63K
-Depreciation and amortization 17.63%122.4K-6.88%104.05K10.38%111.75K16.86%101.23K--86.63K
Other taxes 26.29%8.41K-5.45%6.66K72.63%7.05K17.17%4.08K--3.48K
Other operating expenses -114.34%-123.11K571.33%858.3K-175.58%-182.1K449.36%240.93K---68.96K
Operating profit 18.54%-3.13M-106.99%-3.84M-7.43%-1.86M-37.57%-1.73M-1.26M
Net non-operating interest income expense 26.84%297.36K290.48%234.44K-7.65%-123.08K-8.35%-114.33K-105.52K
Non-operating interest income 11.18%317.67K13,525.13%285.72K-37.76%2.1K--3.37K--0
Non-operating interest expense -60.39%20.31K-59.03%51.28K6.35%125.18K11.54%117.7K--105.52K
Other net income (expense) 159.40%311.31K54.43%-524.11K-449.29%-1.15M63.51%-209.39K-573.86K
Gain on sale of security 175.49%297.55K-1,391.77%-394.16K-178.68%-26.42K-2,089.61%-9.48K---433
Earnings from equity interest 144.12%13.77K7.00%-31.2K84.22%-33.55K---212.58K--0
Special income (charges) --0--0--280--0--0
-Gain on sale of property,plant,equipment --0--0--280--0--0
Other non- operating income (expenses) ----90.94%-98.75K-8,709.51%-1.09M102.21%12.67K---573.42K
Income before tax 38.98%-2.52M-32.04%-4.13M-52.53%-3.13M-6.01%-2.05M-1.94M
Income tax 0-60.18%6531.64K00
Net income 38.98%-2.52M-31.99%-4.13M-52.61%-3.13M-6.01%-2.05M-1.94M
Net income continuous Operations 38.98%-2.52M-31.99%-4.13M-52.61%-3.13M-6.01%-2.05M---1.94M
Minority interest income -1,784.31%-5.16K-12.76%-2743.95%-243-36.02%-253-186
Net income attributable to the parent company 39.11%-2.52M-31.99%-4.13M-52.62%-3.13M-6.00%-2.05M-1.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 39.11%-2.52M-31.99%-4.13M-52.62%-3.13M-6.00%-2.05M-1.94M
Basic earnings per share 43.59%-0.22-36.26%-0.39-52.62%-0.2862-6.00%-0.1875-0.1769
Diluted earnings per share 43.59%-0.22-36.26%-0.39-52.62%-0.2862-6.00%-0.1875-0.1769
Dividend per share
Currency Unit SGDSGDSGDSGDSGD
Audit Opinions Unqualified OpinionUnqualified OpinionUnqualified Opinion with Explanatory Notes----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +67.21%
Sample Name
Sample Code
 +49.51%
Sample Name
Sample Code
 +47.00%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+46.30%
5
United States Gasoline Fund Lp
UGA
+37.41%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +4.14%
Sample Name
Sample Code
 +3.52%
Sample Name
Sample Code
 +3.27%
4
Li Auto
LI
+2.81%
5
Kanzhun
BZ
+1.12%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the prospect of a ceasefire negotiation between the US and Iran has been dominating market sentiment. On March 26 EST, President T Show More
Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

- No more -